Prostate Cancer Clinical Trials in Los Angeles

Showing 221-240 of 325 trials

Focal Laser Ablation of Prostate Tissue

NCT02357121

This is an open-label pilot, feasibility/exploratory study to evaluate the safety of laser interstitial thermal therapy (LITT) using Visualase in the focal ablation of prostate tissue and to gather data for the design of future studies. Intra-procedure temperature and concurrent rectal wall thermistor monitoring will be performed for internal validation. Subjects will be monitored for adverse events, and health-related quality of life (HRQOL) questionnaires will be obtained. Post-treatment MRI and biopsies will be obtained to evaluate histologic and radiologic changes. Biomarker (PSA, PCA3 and PHI) kinetics will also be monitored.

Prostate Cancer

Jonsson Comprehensive Cancer Center11 participantsStarted Sep 2015

Los Angeles, California, United States • Los Angeles, California, United States

COMPLETEDPhase 1< 1 mile

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

NCT00959959

The purpose of this study is to determine whether TOK-001 is safe and shows biological effect in the treatment of castration resistant prostate cancer (CRPC).

Prostate Cancer

LTN PHARMACEUTICALS, INC.49 participantsStarted Oct 2009

Los Angeles, California, United States • San Bernardino, California, United States • Baltimore, Maryland, United States +5 more locations

Focal Laser Ablation of Prostate Tissue

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Prostate Cancer Trials in Other Cities

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Use of Hypothermia During Robotic Prostatectomy

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Defining Recurrent Disease With Axumin™

Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Other Conditions in Los Angeles